TORONTO, June 13 /CNW/ -- Euoko Inc. (OTC Bulletin Board: EUKO), a
developer and marketer of scientifically-studied luxury skin treatments,
announced today that it has incorporated a specific strain of red marine algae
in a proprietary absorption base that will further enhance the activity of its
clinically-studied skin treatments.
Euoko employs unusually high concentrations of scientifically-proven
active ingredients in all of its product line and a key focus of the company
has been maximum exposure of the skin's below-surface layers to these
ingredients. This updated absorption base is the result of more than one year
of research with the aim of improving the penetration of active ingredients
into the skin.
"Euoko's dedication to using the highest concentrations of a wide array
of active components demands a performing delivery system that can take
maximum advantage of the scientifically-demonstrated benefits this unique
active portfolio offers," said Brandon Truaxe, President and CEO. "This
advance supports our continual commitment to developing innovative, effective
treatments that exceed the expectations of the most demanding clientele and we
are pleased to incorporate this base into all existing and new formulations."
The specific strain of red algae, Porphyra sp., causes a controlled
immune response by the body, which in turn increases blood circulation in the
areas of application. This increased circulation optimizes the absorption of
the active ingredients in each product. Combined with Euoko's existing time-
release dosing system that is a key part of its delivery mechanism, this
approach further enhances product performance and reduces treatment times.
"This unique approach to improving product delivery is a prime example of
how advances in biotechnology are creating new possibilities in the field of
skin care," said Dr. Adel Rammal, Director of Scientific Affairs. "This
innovation pushes the accepted boundaries of product performance and I am
excited to be a part of Euoko's ongoing effort to develop solutions that
surpass the accepted realms of skin care science."
About Euoko (www.euoko.com):
Euoko (OTC Bulletin Board: EUKO) is an emerging luxury brand that
develops, markets and distributes scientifically-advanced skin treatments.
Euoko's current portfolio spans five treatment collections that target aging,
dull skin tones, skin protection, uneven pigmentation and blemishes. This
product line offers comprehensive solutions to such skin concerns as wrinkles,
fine lines, under-eye dark circles, dark spots, cellulite, acne, oxidation,
environmental exposure and skin fatigue. Combined with innovative products for
basic daily cleansing and facial priming, Euoko offers a complete line of
synergistic formulations that target the most demanding luxury consumer.
Euoko's well-appointed, understated primary and secondary packaging
communicates innovation, science and sophistication, while reflecting the
prestige positioning of the portfolio. Euoko sells its product line through
varied distribution channels in select North American, European and Middle
Eastern markets, as well as globally through its internally-operated,
multicurrency, multilingual website (www.euoko.com).
For further information:
For further information: Carmela Tassone of Euoko Inc., +1-858-366-4250
x 103 Web Site: http://www.euoko.com/